Thind - Research interests

I am passionate about computational genomics and multi-omics integration for understanding disease progression and identifying clinically relevant biomarkers. My research focuses on combining genomic, transcriptomic, epigenomic, proteomic, and other molecular data layers with advanced statistical and computational approaches to uncover biological mechanisms driving disease outcomes.

A major focus of my work is cancer genomics and biomarker discovery, particularly applying integrative multi-omics approaches to investigate tumour evolution, molecular drivers of progression, and factors associated with metastatic risk. By leveraging bulk and single-cell sequencing, spatial omics, and clinical data integration, my research aims to identify robust molecular signatures that can support improved risk stratification, early detection, and personalised approaches to cancer management.

I am particularly interested in developing reproducible computational frameworks and statistical methodologies for analysing complex biological datasets, ensuring that biomarker discoveries are robust, interpretable, and translatable into clinical research settings.

Through the integration of genomics, multi-omics analytics, statistical bioinformatics, and translational computational biology, my goal is to contribute to collaborative research programs that bridge molecular discovery with real-world biomedical applications.

Omics Analytics for Research Insight

My research in omics analytics focuses on extracting meaningful biological insights from complex, high-dimensional, and heterogeneous datasets. This includes the application of multi-omics integration, differential and compositional analysis, single-cell genomics, and spatial omics approaches to understand molecular mechanisms underlying health and disease.

I have a particular research interest in cancer genomics and immuno-informatics, leveraging bulk, single-cell, and spatial omics technologies to investigate tumour evolution, immune microenvironment dynamics, cellular interactions, and molecular determinants of disease progression.

By developing integrative analytical frameworks and reproducible computational pipelines, my work aims to bridge quantitative modelling with biological interpretation, enabling robust discovery and translation of omics findings into clinically relevant insights.

Statistics for Omics

My research training focuses on the development and application of statistical methodologies for high-dimensional omics data analysis. I am interested in statistical study design, analytical frameworks, and computational strategies for integrating genomic, transcriptomic, proteomic, metabolomic, single-cell, and spatial omics datasets.

A key focus of my work is ensuring that omics studies are designed and analysed using principled statistical approaches, with appropriate consideration of experimental variation, batch effects, uncertainty quantification, multiple testing, and reproducibility.

Through rigorous statistical modelling and computational approaches, I aim to improve the reliability, interpretability, and translational impact of modern omics studies by distinguishing genuine biological signals from technical and analytical artefacts.